Clinical Trial

A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease

Name: A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease — clinical trial record (NCT07536061)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a first-in-human, multi-center trial studying the effects of SRP-1005 in participants with Huntington's disease (HD).

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-05

Trial Details

NCT Number	NCT07536061
Lead Sponsor	Sarepta Therapeutics, Inc.
Conditions	Huntington's Disease
Enrollment	32 participants
Start Date	2026-05-12
Primary Completion	2027-11-30 (estimated)
Study Completion	2027-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-04